Spoligotyping and Mycobacterium tuberculosis.We evaluated the clinical usefulness of spoligotyping, a polymerase chain reaction-based method for simultaneous detection and typing of Mycobacterium tuberculosis Mycobacterium tuberculosis
Mycobacterium tuberculosis strains, with acid-fast bacilli-positive slides from clinical specimens or mycobacterial mycobacterial
emanating from or pertaining to mycobacterium.
may be caused by Mycobacterium tuberculosis (see cutaneous tuberculosis), M. cultures. Overall sensitivity and specificity were 97% and 95% for the detection of M. tuberculosis M. tuberculosis,
n the bacterium responsible for tuberculosis, generally a respiratory infection in man; nonrespiratory tuberculosis is considered an indicator disease for AIDS. See also tuberculosis. and 98% and 96% when used with clinical specimens. Laboratory turnaround time (1) In batch processing, the time it takes to receive finished reports after submission of documents or files for processing. In an online environment, turnaround time is the same as response time. of spoligotyping was less than that for culture identification by a median of 20 days. In comparison with IS6110-based restriction fragment length polymorphism restriction fragment length polymorphism
n. Abbr. RFLP
Intraspecies variations in the length of DNA fragments generated by the action of restriction enzymes and caused by mutations that alter the sites at which these enzymes act, changing typing, spoligotyping overestimated the number of isolates with identical DNA fingerprints by [approximately equal to] 50%, but showed a 100% negative predictive value The negative predictive value is the proportion of patients with negative test results who are correctly diagnosed. Worked example
(as determined by "Gold standard")
True False . Spoligotyping resulted in the modification of ongoing antimycobacterial treatment in 40 cases and appropriate therapy in the absence of cultures in 11 cases. The rapidity of this method in detection and typing could make it useful in the management of tuberculosis in a clinical setting.
The last decade has seen a dramatic resurgence in the incidence of tuberculosis throughout the world and an increased need for more rapid methods to diagnose and prevent dissemination of this disease (1). Well-equipped clinical laboratories can detect tuberculosis cases within 14 to 21 days by using liquid culturing systems such as BACTEC (Becton Dickinson BD (NYSE: BDX), is a medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs 27,000 people in nearly 50 countries. , Sparks, MD, USA). Moreover, several studies have verified the usefulness of nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. amplification--based methods for diagnosis of Mycobacterium tuberculosis infections in <24 hours (2-4). Concomitantly, recently characterized molecular markers for typing mycobacterial strains have greatly facilitated and improved the study of tuberculosis epidemiology (5-8).
Restriction fragment length polymorphism (RFLP RFLP
restriction fragment length polymorphism
restriction fragment length polymorphism.
RFLP ) typing with insertion element IS6110 as a probe has become the most widely used method for differentiating strains of M. tuberculosis isolates (7,8). However, because the application of RFLP typing is restricted to mycobacterial cultures, 20-40 days are required before sufficient mycobacteria mycobacteria
members of the genus Mycobacterium.
see opportunist (atypical) mycobacteria (below).
see opportunist (atypical) mycobacteria (below). are available to obtain sufficient DNA DNA: see nucleic acid.
or deoxyribonucleic acid
One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. needed for this method. This time restriction limits the usefulness of RFLP typing, especially in studying possible nosocomial nosocomial /noso·co·mi·al/ (nos?o-ko´me-il) pertaining to or originating in a hospital.
1. Of or relating to a hospital.
2. transmission of tuberculosis in a clinical setting.
Spoligotyping, a new method for simultaneous detection and typing of M. tuberculosis complex bacteria, has been recently developed (9-11). This method is based on polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is (PER) amplification of a highly polymorphic polymorphic - polymorphism direct repeat locus in the M. tuberculosis genome. Results can be obtained from a M. tuberculosis culture within 1 day. Thus, the clinical usefulness of spoligotyping is determined by its rapidity, both in detecting causative bacteria and in providing epidemiologic information on strain identities. Implementing such a method in clinic settings would be useful in surveillance of tuberculosis transmission and in interventions to prevent further spread of this disease.
The aims of this study were to evaluate 1) the reliability of spoligotyping when used with clinical specimens, 2) the potential usefulness of the method in distinguishing M. tuberculosis from other nontuberculous mycobacteria Nontuberculous mycobacteria (NTM), or atypical mycobacteria or mycobacteria other than tuberculosis (MOTT), are mycobacteria which do not cause tuberculosis or Hansen's disease (leprosy). (primarily M. avium), and 3) the feasibility and impact of spoligotyping in managing tuberculosis in clinical settings.
Patients and Methods
We conducted a 2-year survey of suspected cases of tuberculosis with spoligotyping of acid-fast bacilli bacilli /ba·cil·li/ (bah-sil´i) plural of bacillus.
see bacillus. (AFB AFB
AFB Acid-fast bacillus, also 1. Aflatoxin B 2. Aorto-femoral bypass )-positive specimens collected consecutively from January 2000 to December 2001 in the Microbiology Laboratory at L. Sacco Hospital in Milan. Three types of specimens were included. The first was material scraped from slides prepared from all Ziehl-Neelsen--positive clinical specimens, which were obtained from patients admitted to the hospital. These clinical specimens included sputum sputum /spu·tum/ (spu´tum) [L.] expectoration; matter ejected from the trachea, bronchi, and lungs through the mouth.
sputum cruen´tum bloody sputum. , bronchoalveolar lavage Bronchoalveolar lavage
A way of obtaining a sample of fluid from the airways by inserting a flexible tube through the windpipe. Used to diagnose the type of lung disease. , bone marrow aspirate as·pi·rate
To take in or remove by aspiration.
A substance removed by aspiration.
The removal by suction of a fluid from a body cavity using a needle. , feces, cerebrospinal fluid cerebrospinal fluid (CSF)
Clear, colourless liquid that surrounds the brain and spinal cord and fills the spaces in them. It helps support the brain, acts as a lubricant, maintains pressure in the skull, and cushions shocks. , and urine. The second was samples obtained from liquid culture medium containing growing mycobacteria (BACTEC, Becton Dickinson). The third was a mycobacterial colony grown on solid medium (Lowenstein-Jensen). The hospital microbiology laboratory conducted isolation (both in solid and liquid media), identification, and antimicrobial susceptibility testing by using standard methods (12) on all specimens. The results of spoligotyping were immediately provided to the physicians treating the patients.
Demographic and epidemiologic data were obtained from the medical records of all patients with AFB-positive specimens, including medical history of mycobacteriosis, HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. status, dates and results of mycobacterial smears, signs, symptoms, radiographs of patients with tuberculosis, and CD4+ cell counts (for HIV-infected patients). Data regarding the response time of the method used, possible variation in treatments following spoligotyping results, and patient clinical responses were also obtained.
Isolation of DNA
DNA was isolated from AFB-positive slides as previously described (13). Briefly, stained microscopic preparations were washed in xylol xylol (zī´lôl),
n See xylene. and absolute ethanol, scraped with a sterile blade, and collected in a microcentrifuge tube in 1 x phosphate buffer. The samples were centrifuged for 10 min at 13,000 rpm. The pellets were resuspended in 100 [micro]L lysis buffer A lysis buffer is used for the purpose of lysing cells for use in experiments that analyze the compounds of the cells (e.g. western blot). There are many different kind of lysis buffers that one can apply, depending on what analysis the cell lysate will be used for. (10 mmol/L Tris-HCl, 50 mmol/L KC1, 2.5 mmol/L Mg[Cl.sub.2] 0.45% Tween tween
A child between middle childhood and adolesence, usually between 8 and 12 years old.
[Blend of teen1 and between.] 20, 0.45% Nonidet P40, and 10 mg/mL proteinase proteinase /pro·tein·ase/ (pro´ten-as?) endopeptidase.
A protease that begins the hydrolytic breakdown of proteins usually by splitting them into polypeptide chains. K) and incubated for 3 h at 56[degrees]C or overnight at 37[degrees]C. The samples were then incubated for 15 min at 95[degrees]C and centrifuged for 15 min at 13,000 rpm, and the supernatants were transferred to a new microcentrifuge tube and used in PCR PCR polymerase chain reaction.
polymerase chain reaction
Polymerase chain reaction (PCR) . Mycobacteria were grown in culture, and their DNA was isolated as previously described (6).
RFLP Fingerprinting Analysis and Spoligotyping
Isolates of M. tuberculosis were genotyped by RFLP using the IS6110 probe as a genetic marker genetic marker
A gene phenotypically associated with a particular, easily identified trait and used to identify an individual or cell carrying that gene. , as previously described by van Embden et al. (6). Spoligotyping was performed on genomic DNA genomic DNA
The full complement of DNA contained in the genome of a cell or organism. by using the standard method described by Kamerbeek et al. (9). Control samples were used in these procedures as previously described (14).
Computer-assisted Analysis of Typing Patterns
Gel Compar software version 4.1 (Applied Maths, Kortrijk, Belgium) was used to compare the hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun)
1. crossbreeding; the act or process of producing hybrids.
2. molecular hybridization
3. patterns obtained by spoligotyping and RFLP fingerprinting. The software clustered strains with the same genotypic pattern and defined similarity dendrograms joining the obtained clusters. The results of the analysis were compared with our database containing all DNA patterns derived from tuberculosis cases analyzed (the database contains RFLP data from >4,500 different isolates in our region).
The sensitivity and specificity of spoligotyping in distinguishing M. tuberculosis from nontuberculous mycobacteria were calculated in comparison with culture results that excluded analysis of patients without culture confirmation. The sensitivity and specificity of spoligotyping in typing M. tuberculosis isolates were calculated in comparison with IS6110 clustering.
Three hundred fifty AFB-positive slides from 164 episodes of suspected mycobacteriosis in 148 patients were analyzed. One hundred seven slides were obtained from fresh material: sputum (n = 65), stool (n = 19), lymph node lymph node
Small, rounded mass of lymphoid tissue contained in connective tissue. They occur all along lymphatic vessels, with clusters in certain areas (e.g., neck, groin, armpits). aspirate (n = 12), bronchoaspirate (n = 4), urine (n = 3), skin biopsy Skin Biopsy Definition
A skin biopsy is a procedure in which a small piece of living skin is removed from the body for examination, usually under a microscope, to establish a precise diagnosis. (n = 2), biliar liquid (n = 1), and pericardial fluid (Physiol.) a serous fluid of a pale yellow color contained in the pericardium.
See also: Pericardiac (n = 1). One hundred five samples were obtained after growth of mycobacteria from liquid medium, and 138 samples derived from culture of different materials (mainly blood, but also sputum, bone marrow aspirate, cerebral spinal fluid spinal fluid
See cerebrospinal fluid. , and others) were obtained after growth on solid medium. The characteristics of the 148 patients are shown in Table 1.
Sensitivity and Specificity of Spoligotyping versus Culture
Culture confirmation was obtained in 317 (90.6%) of 350 AFB-positive slides from 138 of 164 episodes of suspected mycobacteriosis (Table 2). M. tuberculosis was isolated from 188 specimens from 77 patient episodes. Among these, isoniazid isoniazid (ī'sōnī`əzĭd), drug used to treat tuberculosis. Also known as isonicotinic acid hydrazide, isoniazid is the most effective antituberculosis drug currently available. resistance was detected in 12 patients (15.6%), rifampin rifampin (rĭfăm`pĭn), antibiotic used in the treatment of tuberculosis. It is also used to eliminate the meningococcus microorganism from carriers and to treat leprosy, or Hansen's disease. resistance in 11 patients (14.3%), streptomycin streptomycin (strĕp'tōmī`sĭn), antibiotic produced by soil bacteria of the genus Streptomyces and active against both gram-positive and gram-negative bacteria (see Gram's stain), including species resistant to other resistance in 4 patients (5.2%), and ethambutol ethambutol /etham·bu·tol/ (e-tham´bu-tol) an antibacterial, specifically effective against Mycobacterium; used with one or more other antituberculous drugs in the treatment of pulmonary tuberculosis, administered as the resistance in 2 patients (2.6%). We also observed 6 patients with multidrug-resistant tuberculosis (resistance to at least isoniazid and rifampin). Fifty-six patients (72.7%) were infected with a strain susceptible to all 4 drugs.
One hundred ninety-eight of 350 AFB slides showed positive results by spoligotyping. Culture results confirmed the diagnosis of tuberculosis according to according to
1. As stated or indicated by; on the authority of: according to historians.
2. In keeping with: according to instructions.
3. spoligotyping positivity in 182 (96.8%) of these 198 specimens. We did not observe definitive growth of mycobacteria in cultures from 10 patients. The PCR products obtained from 6 specimens of nontuberculous mycobacteria (2 M. xenopi, 2 M. fortuitum, and 2 M. avium) hybridized with M. tuberculosis-specific oligonucleotides, which indicated that that false-positive spoligotyping results were possible. However, mixed infections with 2 different mycobacteria cannot be ruled out.
The spoligotyping response was negative in specimens from 152 patients: 23 specimens showed no growth in culture, 123 were nontuberculous mycobacteria, and 6 showed growth characteristic of M.. tuberculosis (Table 2). Three of these 6 false-negative spoligotyping results were from slides with very high concentrations of AFB, and a positive result was obtained when we repeated the test at a higher dilution (1:10).
In comparison with culture results, the sensitivity of spoligotyping was 98% for clinical specimens, 91% for slides obtained from liquid medium, and 100% for slides obtained directly from a mycobacterial colony on Lowenstein-Jensen solid medium. The corresponding specificities were 96% (clinical specimens), 98% (liquid medium), and 94% (solid medium), respectively (Table 2).
Clinical Application of Spoligotyping
Under optimal conditions, spoligotyping requires <24 hours for results. However, in the present study, response time was evaluated, taking into consideration routine processing time in the laboratory. The time from receipt of clinical specimens to obtaining spoligotyping results was 1-26 days (median 6 days). However, spoligotyping results from clinical specimens were obtained a median of 20 days (mean [+ or -] SD, 22.9 [+ or -] 18.6) sooner than those obtained by culture confirmation of tuberculosis and a median of 29 days (35.0 [+ or -] 25.2) sooner than those obtained by susceptibility testing. In contrast, RFLP typing results were obtained after a median of 75 days (range 24-160) (Table 3).
The use spoligotyping in determining treatment for 164 episodes of suspected mycobacteriosis was evaluated (Figure 1). In 25 episodes, patients did not begin antimycobacterial treatment because clinicians judged the AFB results to be not suggestive of suggestive of Decision making adjective Referring to a pattern by LM or imaging, that the interpreter associates with a particular–usually malignant lesion. See Aunt Millie approach, Defensive medicine. true mycobacteriosis; none of these patients had clinical and radiologic features of tuberculosis (virtually all of these were infections with M. gordonae and M. xenopi isolates). Four patients died within a few days after admission without receiving any antimycobacterial drug.
[FIGURE 1 OMITTED]
Clinicians waited until spoligotyping results were obtained before choosing the appropriate therapy for 31 other patients. Subsequently, 20 patients began standard antituberculosis regimens (isoniazid, rifampin, pyrazinamide, and/or ethambutol), whereas the 11 other patients began treatment for infection with M. avium (clarithromycin, ethambutol, rifabutin, and/or ciprofloxacin ciprofloxacin /cip·ro·flox·a·cin/ (sip?ro-flok´sah-sin) a synthetic antibacterial effective against many gram-positive and gram-negative bacteria; used as the hydrochloride salt.
n. ). In all cases, the choice of the treatment based on spoligotyping was not changed after culture and susceptibility test results were obtained.
1. One who is guided by practical experience rather than precepts or theory.
2. An unqualified or dishonest practitioner; a charlatan.
2. antimycobacterial therapy was given to the remaining 104 patients before spoligotyping results were obtained. Seventy-six of these patients received antituberculosis treatment against M. tuberculosis infections, and 28 received therapy for infection with M. avium based on clinical presentation. Therapy was subsequently modified as a result of the spoligotyping results in 14 of these 104 patients. In 5 patients in whom spoligotyping results were negative and subsequent cultures showed nontuberculous mycobacteria, antituberculosis treatment was replaced with treatment for infection with M. avium. In contrast, in 8 patients in whom spoligotyping results were positive and subsequent cultures were positive for M. tuberculosis, treatment for infection with M. avium was replaced by antituberculosis treatment. In 1 patient, the homology homology (hōmŏl`əjē), in biology, the correspondence between structures of different species that is attributable to their evolutionary descent from a common ancestor. of the spoligotyping pattern with patterns of other patients included in our data bank demonstrated that the isolate originated from an outbreak caused by multidrug-resistant strains. Consequently, therapy was modified to include second-line antituberculosis drugs Antituberculosis Drugs Definition
Antituberculosis drugs are medicines used to treat tuberculosis, an infectious disease that can affect the lungs and other organs. , which previous in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.
In an artificial environment outside a living organism. susceptibility data had shown were active against the specific strains. Subsequent in vitro susceptibility data confirmed the spoligotyping results. False-positive spoligotyping results in 9 patients did not result in errors in prescribing treatment. These patients continued ongoing treatment, primarily on the basis of previous spoligotyping results or because of a positive response to treatment.
Analysis of Different Isolates from the Same Patient
We analyzed 34 spoligotyping-positive specimens from 6 patients with successive episodes of culture-confirmed tuberculosis ([greater than or equal to] 3 months apart). In these patients, spoligotyping was modified to distinguish relapses from new infections. After the samples were decoded, all episodes were classified as true relapses, and no new infections were detected. The banding patterns of the successive specimens matched those of their corresponding initial isolates. The subsequent RFLP results confirmed those obtained with spoligotyping.
The reproducibility of spoligotyping was demonstrated by the identity of results obtained with clinical samples and corresponding cultures from different anatomic sites in the same episode (18 patients), and from episodes of recurrent tuberculosis in the same person (5 patients). Thirty-nine distinct spoligotyping patterns were observed; 55% of the specimens were grouped into 10 clusters, and the others had unique spoligotypes. Sixty-one different RFLP patterns were seen in 64 isolates. Of these 61 patterns, 3 were shared by 2 isolates, while the remaining 58 patterns (95%) were observed in only 1 isolate.
One of the 3 clusters identified by RFLP was a false cluster because it showed a 1-band pattern that correctly matched 2 different spoligotypes. In the remaining 2 RFLP clusters, complete concordance concordance /con·cor·dance/ (-kord´ins) in genetics, the occurrence of a given trait in both members of a twin pair.concor´dant
n. with spoligotyping was observed. The remaining 8 clusters detected by spoligotyping were not confirmed by RFLP analysis. Therefore, although it demonstrated 100% sensitivity, spoligotyping overestimated the number of clustered isolates by [approximately equal to] 50% (specificity 47.5%). Conversely, RFLP analysis had 100% specificity, but lower sensitivity. However, most of the isolates classified as clustered by spoligotyping but not by RFLP showed >50% similarity in their IS6110 patterns (Figure 2). Using spoligotyping of clinical samples without culture confirmation we were able to diagnose an M. bovis infection and rapidly identify 2 cases of recurrent tuberculosis in patients with the same spoligotyping pattern in both followup specimens and the initial M. tuberculosis strain isolated several months earlier.
[FIGURE 2 OMITTED]
Recent characterization of biologic markers for typing M. tuberculosis strains has greatly facilitated and improved tuberculosis epidemiology. IS6110 RFLP typing is the most widely used method for differentiating M. tuberculosis strains (15-19). However, RFLP analysis requires growth of mycobacterial colonies, which involves a consistent lag time between epidemiologic events and typing results. Thus, time remains a limiting factor A factor or condition that, either temporarily or permanently, impedes mission accomplishment. Illustrative examples are transportation network deficiencies, lack of in-place facilities, malpositioned forces or materiel, extreme climatic conditions, distance, transit or overflight rights, in obtaining a highly effective method for epidemiologic surveys and preventing the spread of disease.
The development of new PCR-based typing methods (4,5,9,10,20-23) has allowed rapid mycobacterial identification to be combined with epidemiologic typing results. Thus, molecular epidemiologic information can be combined in the context of epidemic events and tuberculosis transmission. Spoligotyping appears to have the specific characteristics needed to satisfy these issues of epidemics and tuberculosis transmission (24-28). This method permits the concomitant identification and differentiation of M. tuberculosis strains and avoids the timing problems associated with the slow growth of these bacteria (10,11). However, although spoligotyping can be used with clinical specimens (9), the usefulness of any PCR-based typing method in the clinical setting has yet to be demonstrated. In addition, although previous studies have investigated the effect of specific methodologic issues on the performance of several typing techniques (20-22,24-30), we have demonstrated the usefulness of a PCR-based technique in the clinical setting for diagnostic purposes, as well as for epidemiologic studies of tuberculosis transmission.
We have also shown that spoligotyping can be satisfactorily used with clinical samples. The performance of spoligotyping was satisfactory with all clinical specimens used, and its specificity and sensitivity were 98% and 96%, respectively. These features are comparable with those of commercial PCR methods used for detecting M. tuberculosis from clinical samples (19). Moreover, the opportunity to combine rapid diagnostic information and molecular epidemiologic data represents an important advance in the epidemiologic control of tuberculosis.
Several molecular typing studies have compared different methods for M. tuberculosis typing. IS6110-based RFLP has been found to be more discriminative dis·crim·i·na·tive
1. Drawing distinctions.
2. Marked by or showing prejudice: discriminative hiring practices. than direct repeat-based spoligotyping (20-31). Although our data confirm that spoligotyping vastly overestimates the number of clustered isolates, this method has a lower discriminatory power than IS6110-RFLP. However, spoligotyping also has a higher negative predictive value, thus enabling the clinician to exclude a particular clustered strain as a cause of infection, if known drug-resistant variants are present.
This study showed that spoligotyping can provide useful data to clinicians in different settings. Although co-infection with M. tuberculosis and nontuberculous mycobacteria cannot be ruled out, the ability to differentiate between M. tuberculosis and other mycobacteria was demonstrated in 27% of the patients. Some patients began therapy after evaluation of spoligotyping results, while others changed treatments because spoligotyping did not confirm the initial diagnosis. Time of response for spoligotyping was shorter than that of culture confirmation of tuberculosis by a median of 20 days and that of susceptibility results by a median of 29 days. In addition, a median of 6 days was needed for obtaining spoligotyping results, compared with 75 days for RFLP typing results.
Comparison of molecular typing patterns identified 6 patients with reactivation reactivation
to become active after a period of quiescence or, as in bacterial and viral infections, latency.
cross reactivation of tuberculosis caused by the same strain of M. tuberculosis, a finding that can differentiate between relapse and new infection in a new episode of tuberculosis. In 1 patient, we found that the spoligotyping pattern was identical to that of other strains that belonged to a cluster of multidrug-resistant tuberculosis. This observation resulted in the modification of antituberculosis treatment 34 days before susceptibility data were available. Moreover, information obtained by spoligotyping was relevant and useful in therapeutic management of [approximately equal to] 33% of the patients.
The clinical utility of spoligotyping may not be fully apparent by analyzing the results of this study, primarily because of the lack of clustered episodes of tuberculosis during the study period. However, spoligotyping would have been useful during a period or in a setting characterized by the emergence of M. tuberculosis outbreaks (8,32,33). We have also shown that the usefulness of spoligotyping is increased when results are compared with data on other tuberculosis patients and a DNA database on M. tuberculosis strains.
In conclusion, this study underscores the need to implement rapid molecular epidemiologic methods in managing tuberculosis epidemics. We have shown that spoligotyping is a useful method for screening and epidemiologic control of tuberculosis dissemination, particularly when results are required quickly, such as in outbreaks, or in the management of transmission of multidrug-resistant tuberculosis, especially in restricted high-risk situations such as prisons, schools, and hospitals.
Table 1. Characteristics of 148 patients with acid-fast bacilli in bioloaic specimens * Age, y Median (range) 34(3-88) Mean 39.3 Sex, no. (%) Male 105 (70.9) Female 43 (29.1) Type of patient, no. (%) Infectious diseases 124 (83.8) Pneumology 10 (6.8) Internal medicine 10 (6.8) Other 4 (2.7) HIV status, no. (%) Negative 52 (35.1) Positive 96 (64.9) CD4+ cell count/[micro]UL ([dagger]) Median 47.5 Mean (range) 105 (1-589) Previous tuberculosis, no. (%) 20 (13.5) Previous MAC infection, no. (%) 10 (6.8) No tuberculosis or MAC infection, no. (%) 118 (79.7) * MAC, Mycobacterium avium complex. ([dagger]) Data available for 90 of 96 HIV-infected patients. Table 2. Comparison between spoligotyping and culture results in 350 acid-fast bacilli--positive samples Mycobacteria grown No. in culture episodes M. tuberculosis 77 M. avium 28 M. gordonae 15 M. xenopi 8 M. kansasii 2 M. chelonae 2 * Other 6 ([dagger]) No growth 26 Subtotal Total 164 ([double dagger]) Sensitivity, % ([section]) Specificity, % ([section]) Results of Results of spoligotyping from spoligotyping from clinical samples liquid medium Mycobacteria grown in culture Positive Negative Positive Negative M. tuberculosis 54 1 53 5 M. avium 0 15 0 20 M. gordonae 0 0 0 12 M. xenopi 0 2 1 5 M. kansasii 0 1 0 0 M. chelonae 0 2 0 2 Other 1 1 0 4 No growth 9 21 1 2 Subtotal 64 43 55 50 Total 107 105 Sensitivity, % ([section]) 98.2 (71.1-98.4) 91.4 (75.7-90) Specificity, % ([section]) 95.5 (67.7-97.7) 97.7 (95.6-97.8) Results of spoligotyping from solid medium Total Mycobacteria grown in culture Positive Negative Positive Negative M. tuberculosis 75 0 182 6 M. avium 2 31 2 66 M. gordonae 0 14 0 26 M. xenopi 1 6 2 13 M. kansasii 0 2 0 3 M. chelonae 0 2 0 6 Other 1 4 2 9 No growth 0 0 10 23 Subtotal 79 59 198 152 Total 138 350 Sensitivity, % ([section]) 100 96.8 (86.2-97) Specificity, % ([section]) 93.6 95.3 (88.4-96.1) * Automated UNA sequencing rather than culture growth of M. chelonae confirmed one of these cases. ([dagger]) Other, 1 M. fortuitum, 1 M. asiaticum, and 4 nontyped mycobacteria. ([double dagger]) 16 patients had [greater than or equal to] 2 episodes of mycobacterial infections. ([section]) Sensitivity and specificity were calculated without including the culture-negative specimens. Values in parentheses are ranges that include specimens with no growth. Table 3. Time required for obtaining results with clinical specimens by spoligotyping compared with 3 other methods * Procedure Days required, median (range) Spoligotyping 6 (1-26) Culture confirmation 28 (6-64) Susceptibility testing 37 (23-81) RFLP typing 75 (24-160) * RFLP, restriction fragment length polymorphism.
We thank the patients of the infectious diseases infectious diseases: see communicable diseases. ward and outpatient clinic at L. Sacco Hospital for their participation; the staff of the Department of Infectious Diseases, L. Sacco Hospital, and the Institute of Infectious Disease Infectious disease
A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. , University of Milan The university is a member of the League of European Research Universities.
Throughout Milan, the University is normally known as Statale to avoid confusion with other academic institutions in the city. , including Cecilia Paoli, Patrizia Franza, and Cristina Bessi, for their assistance; Carmela Pema for her contribution in coordinating the study; Michael Alan Rosen and Shane Fogden for their assistance in the English revision of the text; and Annalisa Angelantoni for her continuous support.
This work was supported by grants from the National Institute of Health, Minister of Health, 1% 2000, project 0AL/F and RF/101, Rome, Italy; and the AHSI AHSI African Human Security Initiative
AHSI Alternative High School Initiative
AHSI Arabian Horse Society of Iowa
AHSI Arkansas History Summer Institute Company, Milan, Italy.
(1.) Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burned of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-21.
(2.) Brisson-Noel A, Gicquel B, Lecossier D, Levy-Frebault V, Nassif X, Hance AJ. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet. 1989;2:1069-71.
(3.) Clarridge JE III, Shawar RM, Shinnick TM, Plikaytis BB. Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol. 1993;31:2049-56.
(4.) Eisenach KD, Cave MD, Bates Bates , Katherine Lee 1859-1929.
American educator and writer best known for her poem "America the Beautiful," written in 1893 and revised in 1904 and 1911. JH, Crawford JT. Polymerase chain reaction amplification of a repetitive DNA sequence DNA sequence Genetics The precise order of bases–A,T,G,C–in a segment of DNA, gene, chromosome, or an entire genome. See Base pair, Base sequence analysis, Chromosome, Gene, Genome. specific for Mycobacterium tuberculosis. J Infect Dis. 1990;161:977-81.
(5.) van Soolingen D, de Haas de Haas as a surname can refer to:
n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation.
PMA Progressive muscular atrophy , van Embden JDA JDA Japan Defense Agency
JDA Joint Development Agreement
JDA Janne da Arc (band)
JDA Joint Duty Assignment
JDA Jerusalem Development Authority
JDA Jovian Detention Authority (gaming) . Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol. 1993;31:1987-95.
(6.) van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting DNA fingerprinting or DNA profiling, any of several similar techniques for analyzing and comparing DNA from separate sources, used especially in law enforcement to identify suspects from hair, blood, semen, or other biological materials found at : recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
(7.) Behr MA, Small PM. Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician? Clin Infect Dis. 1997;25:806-10.
(8.) Franzetti F, Gori Gori (gô`rē), city (1989 pop. 68,924), central Georgia. It has food processing plants. Mentioned in the 7th cent. as Tontio, it was later named after a fortress. Gori passed to Russia in 1801. Stalin was born in the city. A, Iemoli E, Meraviglia P, Mainini F, Quirino T, et al. Outcome of multidrug resistant tuberculosis in HIV-infected patients. Clin Infect Dis. 1999;29:553-60.
(9.) Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907-14.
(10.) Groenen PMA, Bunschoten AE, van Soolingen D, van Embden JDA. Nature of DNA polymorphism DNA polymorphism
A condition in which one of two different but normal nucleotide sequences can exist at a particular site in a DNA molecule. in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method. Mol Microbiol. 1993;10:1057-65.
(11.) Hermans PWM, van Soolingen D, Bik EM, de Haas PEW, Dale JW, van Embden JDA. Insertion clement IS987 from Mycobacterium bovis Mycobacterium bovis A mycobacterium that causes a TB-like infection in cows; before pasteurization was common, M bovis spread to humans via contaminated milk BCG BCG bacille Calmette-Guérin.
1. bacillus Calmette-Guérin
n.pr See bacille Calmette-Guórin. is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun. 1991;59:2695-705.
(12.) Metchock BG, Nolte FS, Wallance RJ Jr. Mycobacterium mycobacterium
Any of the rod-shaped bacteria that make up the genus Mycobacterium. The two most important species cause tuberculosis and leprosy in humans; another species causes tuberculosis in both cattle and humans. . In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington: American Society for Microbiology The American Society for Microbiology (ASM) is a scientific organization, based in the United States although with over 43,000 members throughout the world. It is the largest single life science professional organization and its members include those whose interests encompass basic ; 1999. p. 399-437.
(13.) Rossi MC, Gori A, Zehender G, Marchetti G, Ferrario G, de Maddalena C, et al. A PCR-colorimetric microwell plate hybridization assay for detection of M. tuberculosis and M. avium from culture samples and Ziehl-Neelsen positive smears. J Clin Microbiol. 2000;38:1772-6.
(14.) Ferrario G, Gori A, Rossi A, Catozzi L, Molteni C, Marchetti G, et al. PCR-hybridization assay for Mycobacterium avium complex Mycobacterium avium complex (MAC) is a group of genetically-related bacteria belonging to the genus Mycobacterium. It includes Mycobacterium avium subspecies avium (MAA), Mycobacterium avium subspecies hominis (MAH), and : optimization of detection in peripheral blood peripheral blood Cardiology Blood circulating in the system/body from humans. J Clin Microbiol. 2001;39:1638-43.
(15.) Beck-Sague C, Dooley SW, Hutton MD, Otten J, Breeden A, Crawford JT, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. JAMA JAMA
Journal of the American Medical Association . 1992;268:1280-6.
(16.) Pearson ML, Jereb JA, Frieden TR, Crawford JT, Davis BJ, Dooley SW, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Intern Med. 1992;117:191-6.
(17.) Edlin BR, Tokars JL, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome acquired immunodeficiency syndrome, see AIDS. . N Engl J Med. 1992;326:1514-21.
(18.) Coninx R, Mathieu C. Debacker M, Mirzoev F, Ismaelov A, de Haller R, et al. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet. 1999;353:969-73.
(19.) Drobniewski FA, Gibson A, Ruddy M, Yates MD. Evaluation and utilization as a public health tool of a national molecular epidemiological tuberculosis outbreak database within the United Kingdom from 1997 to 2001. J Clin Microbiol. 2003;41:1861-8.
(20.) Diaz R. Kremer K, de Has PE, Gomez RI, Marrero A, Valdivia JA, et al. Molecular epidemiology molecular epidemiology Molecular medicine An evolving field that combines the tools of standard epidemiology–case studies, questionnaires and monitoring of exposure to external factors with the tools of molecular biology–eg, restriction endonucleases, of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism, Int J Tuberc Lung Dis. 1998;2:743-50.
(21.) Sola C, Horgen L, Maisetti J, Devallois A, Goh KS, Rastogi N. Spoligotyping followed by double-repetitive-element PCR as rapid alternative to IS6110 fingerprinting for epidemiological studies of tuberculosis. J Clin Microbiol. 1998;36:1122-4.
(22.) Goyal M, Saunders NA, van Embden JDA, Young DB, Shaw RJ. Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. J Clin Microbiol. 1997;35:647-51.
(23.) Mazars E, Lesjean S, Banuls AL, Gilbert M, Vincent V, Gicquel B, et al. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A. 2001;98:1901-6.
(24.) Goguet de la Salmoniere YO, Li HM, Torrea G, Bunschoten A, van Embden J, Gicquel B. Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol. 1997;35:2210-4.
(25.) Aranaz A, Liebana E, Mateos A, Dominguez L, Cousins D. Restriction fragment length polymorphism and spacer oligonucleotide typing: a comparative analysis of fingerprinting strategies for Mycobacterium bovis. Vet Microbiol. 1998;61:311-24.
(26.) Roring S, Brittain D, Bunschoten AE, Hughes MS, Skuce RA, van Embden JD, et al. Spacer oligotyping of Mycobacterium bovis isolates compared to typing by restriction fragment length polymorphism using PGRS PGRS Postal Grievance Research System (software) , DR and IS6110 probes. Vet Microbiol. 1998;61:111-20.
(27.) Bauer J, Andersen AB, Kremer K, Miorner H. Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol. 1999;37;2602-6.
(28.) Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K. Pan X, Lutfey ML, et al. Origin and interstate spread of a New York City New York City: see New York, city.
New York City
City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. multidrug-resistant Mycobacterium tuberculosis clone family. JAMA. 1996;275:452-7.
(29.) Moss AR, Alland D, Telzak E, Hewlett D Jr, Sharp V, Chiliade P, et al. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . Int J Tuberc Lung Dis. 1997;1:115-21.
(30.) Alito A, Morcillo N, Scipioni S, Dolmann A, Romano MI, Cataldi A, et al. The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too last for reliable use in outbreak investigation. J Clin Microbiol. 1999;37:788-91.
(31.) Soini H, Pan X, Amin A, Graviss EA, Siddiqui A. Musser JM. Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping. J Clin Microbiol. 2000;38:669-76.
(32.) Moro ML, Gori A, Errante I, Infuso A, Franzetti F, Sodano L, et al. An outbreak of multidrug resistant tuberculosis involving HIV-infected patients of two hospitals in Milan Italy. AIDS. 1998:12:1095-102.
(33.) Moro ML, Salamina G, Gori A, Penati V, Sacchetti R, Mezzetti F, et al. Two-year population-based molecular epidemiological study of tuberculosis transmission in the metropolitan area of Milan, Italy. Eur J Clin Microbiol Infect Dis. 2002;21:114-22.
Andrea Gori, * Alessandra Bandera, * Giulia Marchetti, * Anna Degli Esposti, * Lidia Catozzi, * Gian Piero Nardi, * Lidia Gazzola, * Giulio Ferrario, * Jan D.A. van Embden, ([dagger]) Dick van Soolingen, ([dagger]) Mauro Moroni, * and Fabio Franzetti *
* University of Milan, Milan, Italy; and ([dagger]) National Institute of Public Health and Environmental Protection, Bilthoven, the Netherlands
Dr. Gori is a senior physician at the Institute of Infectious Diseases and Tropical Medicine tropical medicine, study, diagnosis, treatment, and prevention of certain diseases prevalent in the tropics. The warmth and humidity of the tropics and the often unsanitary conditions under which so many people in those areas live contribute to the development and , L. Sacco Hospital, University of Milan. His primary research interests include molecular diagnostics and molecular epidemiology of tuberculosis for clinical applications.
Address for correspondence: Andrea Gori, institute of Infectious Diseases, L. Sacco Hospital, University of Milan, Via GB. Grassi 74, 20157 Milan, Italy; fax: 39-2-356-0805; email: email@example.com